Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024

Multidisciplinary expert consensus on the clinical rational application of different formulations of amphotericin B (2024 edition).

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Overview

Expert consensus demonstrates formulation selection and dosing of amphotericin B in invasive fungal diseases, highlighting standardized application across special patient populations.

Key Points

  • Formulation-specific guidance optimizes therapy for invasive fungal diseases by matching amphotericin B deoxycholate with three lipid-based formulations to improve therapeutic efficacy.
  • Liposomal amphotericin B and amphotericin B lipid complex require distinct dosing strategies based on pharmacokinetics, adverse reaction profiles, and specific clinical indications.
  • Multidisciplinary expert consensus synthesized current clinical research evidence and guidelines to standardize amphotericin B colloidal dispersion administration in special populations.

Cite This Study

A 2024 study studied this question.

synapsesocial.com/papers/68e76353b6db6435876d9a7ahttps://doi.org/10.3760/cma.j.cn112138-20231122-00332
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios2026
  2. 2Amphotericin B in the Era of New Antifungals: Where Will It Stand?2024 · 17 citations
  3. 3Lipid-based amphotericin B formulations (ABCD/L-AmB) were associated with better outcomes than deoxycholate (AmB-d) in non-HIV-associated cryptococcal meningitis: A retrospective cohort study2026
  4. 4Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application2023 · 18 citations
  5. 5FORMULATION AND EVALUATION OF AMPHOTERICIN B-LOADED CUBOSOMES: A COMPREHENSIVE REVIEW2026